WHO ICTRP trial
Secondary prevention of type 1 diabetes in children and adolescents aged 6…
ISRCTN17354692 · International Standard Randomised Controlled Trial Number (ISRCTN) · Recruiting
Key facts
| Trial ID | ISRCTN17354692 |
|---|---|
| Public title | Secondary prevention of type 1 diabetes in children and adolescents aged 6 months - 18 years using oral Vitamin D (calcitriol and analogues) |
| Scientific title | Secondary PREvention of type 1 diabetes with oral CALcitriol and analogues in children and adolescents aged 6 months - 18 yrs |
| Primary sponsor | Pediatric Endocrine Clinics |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Phase II |
| Countries | Cyprus;Greece |
| Conditions | Susceptibility for Type 1 Diabetes, Prediabetes Type 1, Newly diagnosed (subclinical) Type 1 Diabetes Nutritional, Metabolic, Endocrine |
| Interventions | In all children aged six months - 18 yrs either at high risk of T1D (at least 1 positive T1D associated autoantibody: IAA, ICA, anti-GAD, anti-IA2) or a predisposing HLA subtype (A, DQ, DR) or diagnosed as prediabetic with an OGTT (using… |
| Registration date | May 5, 2020 |
| Target size | 50 |
| Secondary IDs | Nil known;Nil known;9/2010 |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: